Congenital heart defects impact approximately 1 in 100 newborns. These defects can be detected during a fetal heart ultrasound exam, according to a Nov. 18 press release.
Misdetection or delayed diagnosis of heart defects can lead to severe consequences and missed opportunities for life-saving interventions.
BrightHeart’s new AI software offers a solution to some of these challenges, allowing clinicians in resource-constrained practices to improve the detection of morphological abnormalities suggestive of CHDs.
The technology is designed to integrate into existing workflows to help reduce the burden of sonographers and OB-GYNs.
BrightHeart was founded just two years ago by pediatric cardiologists Marilyne Levy, MD, and Bertrand Sto, MD.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.